v3.26.1
Earnings Per Share - Schedule of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Effect of potentially dilutive shares:        
Net (loss) income available $ (406,268) $ (248,778) $ 881,493 $ (153,645)
Adjustment for change in fair value on SPA Warrant 0 0 (216,684) 0
Adjustment for change in fair value on April, May and December 2023 Warrants 0 0 (156,633) 0
Adjustment for remeasurement of Series B Preferred Stock 0 0 (648,320) 0
Net (loss) income applicable to common stock $ (406,268) $ (248,778) $ (140,144) $ (153,645)
Weighted-average basic common shares outstanding (in shares) 339,799,132 237,741,328 339,920,441 231,616,540
Dilutive effect of Series B Preferred Stock (in shares) 0 0 116,311,460 0
Dilutive effect of warrants (in shares) 0 0 64,431,326 0
Weighted-average dilutive common shares outstanding (in shares) 339,799,132 237,741,328 531,673,873 231,616,540
Earnings per share:        
Diluted (in dollars per share) $ (1.20) $ (1.05) $ (0.26) $ (0.66)
Restricted stock units        
Effect of potentially dilutive shares:        
Dilutive effect of RSUs, PRSUs and stock options (in shares) 0 0 7,586,514 0
Performance-based restricted stock units        
Effect of potentially dilutive shares:        
Dilutive effect of RSUs, PRSUs and stock options (in shares) 0 0 2,170,718 0
Stock Options        
Effect of potentially dilutive shares:        
Dilutive effect of RSUs, PRSUs and stock options (in shares) 0 0 1,253,414 0